Group items tagged

Prostate cancer is the most common cancer among men in the United Kingdom. However, Macmillan revealed that prostate cancer diagnoses were down 29 per cent between 2019 and 2020, meaning men weren't seeing their GPs to begin to get diagnosed. Therefore, it is of utmost importance to spot any symptoms and get checked, as an early diagnosis can help not only increase survival rates, but also offer a more varied choice of treatment options. As community pharmacy teams play a fundamental role in educating men who may be concerned about their health it vital to maximise trusted relationship with patients, and it is crucial that pharmacists have access to the correct resources to direct men to seek prostate cancer guidance. Prostate cancer often affects men who are over the age of 50. Those who are at a higher risk of prostate cancer also include those of African-Caribbean family descent, if there has been a family history of the cancer, and poor weight and diet. However, studies have found that community pharmacists play an important role in delivering programmes to improve levels of physical activity and diet of men with prostate cancer.

The government has joined hands with Prostate Cancer UK to launch a massive screening trial in the country next year. Called TRANSFORM, the trial will use innovative screening methods like an MRI scan to detect prostate cancer, which is the most common cancer in men in the UK. The trail is scheduled for launch in Spring 2024, and recruitment is likely to begin in Autumn 2024. For the £42 million trial, the government will invest £16 million through the National Institute of Health Research, and £26m will be provided by Prostate Cancer UK. The Department of Health and Social Care (DHSC) believes that thousands of men's lives could be saved each year if prostate cancer is detected early with effective screening methods.

Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise by adding leuprorelin acetate as a branded generic to its oncology portfolio. Leuprorelin acetate is hormone therapy recommended for patients with high-risk localised, locally advanced, and metastatic prostate cancer, serving as an alternative to surgical castration for locally advanced cases. Used as an alternative to surgical castration for locally advanced prostate cancer, a pre-filled syringe containing 11.25mg of leuprorelin acetate (equivalent to 10.72 mg leuprorelin) is injected subcutaneously into the abdomen. The British pharmaceutical company noted that one of its primary objectives is to seek "new investment opportunities" that brings products and companies into its portfolio, aligning closely with Aspire values and therapeutic focus areas. Prostate cancer is the most common cancer among men in the UK, with an average of over 52,000 men receiving a diagnosis of prostate cancer annually, as per Prostate Cancer UK.

Prostate cancer is the most common cancer among men in the United Kingdom, affecting nearly 50,000 men yearly. Combined with the challenges faced across healthcare during COVID-19, new figures show that prostate cancer accounts for a third of cancers not treated due to the pandemic, with 14,000 'missing patients' believed to have not undergone treatment since April 2020. It is more urgent than ever that men are encouraged to get checked, as any set-backs in diagnosis can reduce the pathways available, in turn affecting health outcomes. Community pharmacy teams play a crucial role in signposting the help available for men who may be concerned about their health. Therefore, it is vital that pharmacy teams have access to the information they need to correctly direct men to seek prostate cancer guidance. By maximising the trusted relationship between patients and their pharmacists, more can be done to identify the warning signs, helping men to get an earlier diagnosis.

Prostate cancer is a men problem that mostly bothered them in the old age due to the enlargement of prostate gland. The development of abnormal cells in the male reproductive system inside prostate gland contributes prostate cancer. Increasing growth of the abnormal cells inside the prostate gland damages the normal cells. Unfortunately, there are no premature warning signs of prostate cancer. Especially in men, Prostate cancer grows very slowly without any warning signals.

Aspire Pharma Limited has reaffirmed its commitment to combating prostate cancer by adding leuprorelin acetate as a branded generic to its oncology portfolio. This move solidifies Aspire's position as a leading specialty generics enterprise. Leuprorelin acetate is a hormone therapy recommended for patients with high-risk localized, locally advanced, and metastatic prostate cancer. It serves as an alternative to surgical castration for locally advanced cases. A pre-filled syringe containing 11.25mg of leuprorelin acetate (equivalent to 10.72 mg leuprorelin) is injected subcutaneously into the abdomen, providing a vital treatment option for patients.

It is considered that testosterone replacement can increase the risk of prostate cancer. Based on medical literature support, it is proved that testosterone replacement is not the cause of prostate cancer.

Note that the expressions of malignancy and cancer are also used to describe cancer. The benign tumor is not cancerous, and is less health. It can put pressure on an organ or tissue, but in a limited space and does not spread in the body. Prevalence

In any case, you can report concerning indications to the cancer specialist and avail prostate cancer treatment in Delhi. You can consult from a cancer specialist in Delhi NCR before having radiation therapy.

In any case, you can report concerning indications to the cancer specialist and avail prostate cancer treatment in Delhi. You can consult from a cancer specialist in Delhi NCR before having radiation therapy.

As most of us know cancer are primarily treated by giving radiation therapy, and the same is the case with Prostate cancer. Prostate is basically a gland found only in men and it starts growing even before birth and grows till he achieves adulthood.

Ryan Touchton was diagnosed with prostate cancer, treated with ProstRcision and ultimately beat the disease.watch more videos on www.mytopclip.com

Treatments for prostate cancer can be availed by prostate cancer doctors in Delhi. Cancer specialist in Delhi provide the best prostate cancer treatments.

The King's condition is "benign" and he will be treated in the hospital next week for a "corrective procedure", Buckingham Palace said a statement released on Wednesday. "In common with thousands of men each year, the King has sought treatment for an enlarged prostate," the Palace said. Because of the upcoming surgery, Charles had to postpone all meetings and events planned for this week. The Palace informed that the King's public engagements will be "postponed for a short period of recuperation." Charles, 75, wanted to share the details of his diagnosis to encourage more men who may be experiencing symptoms to get their conditions checked.

A new study by The Institute of Cancer Research, London (ICR) has shown that a genetic test for faults in DNA repair could enable targeted nuclear treatments for patients with prostate cancer.

What initially began as two close friends taking a leisurely walk to escape their everyday routine has evolved into a meaningful endeavour to support the fight against cancer. Jamie Sparrow, Senior Vice President - Commercial, EMENA at Accord Healthcare, and Jamie Durbidge, Owner & Managing Director of Perennial Pharma, will be undertaking a 5-day walking challenge to support The Luke Hart Foundation in raising funds for Cancer Research UK. The two Jamies have been friends for more than 15 years and worked together at Mylan, now Viatris, where Jamie S served as Managing Director, while Jamie D held the position of Sales Director for some years. During the COVID pandemic when everybody was stuck at home, the two friends, both early risers, used to spend hours in the mornings walking and talking over the phone, about anything and everything - work, life, family, the Pharmaceutical Industry, politics, sport, and about challenges that people were having during the lockdown. After continuing this routine for several months, they eventually planned to transform their daily ritual into a "walking and talking" trip to reconnect, catch up on things, and enjoy some time together and with friends who wanted to join them.

In this blog we are describing can eggs increase prostate cancer risk. If you want to know more about this then read this blog and for more information visit at http://cancerconsultindia.com/

Persons having prostate cancer or breast cancer cannot use testosterone replacement therapy because it can cause the cancer to grow more rapidly. Testosterone therapy is used to improve low T levels in human body. However, it has number of negative impacts that everyone should know before using it.

Eggs are a decent source of protein and must be included in a part of the diet, however some research claims that eating more than 2 eggs in a week expands the danger of cancer by a stunning 80 percent and also reveals that even one egg in seven days builds risk as much as 70%. Some of the best cancer doctors in Delhi says that eggs are a rich source of cholesterol.

Diagnostics developer MDNA Life Sciences has partnered with Aspire Pharma to introduce the new Mitomic Prostate Test (MPT) for clinical use in the UK.

Consult a well known cancer specialist to get the treatment. Being the Best Oncologist in Delhi NCR, Dr. Manish singhal is recommended for the same